Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study

被引：0
|
作者：
Sindet-Pedersen, C. [1 ]
Pallisgaard, J. Langtved [1 ]
Gislason, G. Hilmar [1 ]
Staerk, L. [1 ]
Fosboel, E. Loldrup [2 ]
Torp-Pedersen, C. [3 ]
Olesen, J. Bjerring [1 ]
机构：
[1] Copenhagen Univ Hosp, Gentofte Hosp, Cardiol, Hellerup, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark
[3] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5963
引用
收藏
页码：1221 / 1222
页数：2
相关论文
共 50 条
  • [31] Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study
    Riva, Nicoletta
    Di Minno, Matteo N. D.
    Mumoli, Nicola
    Pomero, Fulvio
    Franchini, Massimo
    Bellesini, Marta
    Lupoli, Roberta
    Sabatini, Silvia
    Borretta, Valentina
    Bonfanti, Carlo
    Ageno, Walter
    Dentali, Francesco
    HAEMATOLOGICA, 2015, 100 (08) : E295 - E298
  • [32] Comparison of the Short-Term Bleeding Risk in Nonvalvular Atrial Fibrillation Patients Newly Treated with Dabigatran or Rivaroxaban Versus Vitamin K Antagonists: A French Nationwide Propensity-Matched Cohort Study
    Maura, Geric
    Blotiere, Pierre-Olivier
    Bouillon, Kim
    Billionnet, Cecile
    Ricordeau, Philippe
    Alla, Francois
    Weill, Alain
    Zureik, Mahmoud
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 404 - 404
  • [33] Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice
    Giorgi-Pierfranceschi, Matteo
    Di Micco, Pierpaolo
    Cattabiani, Chiara
    Guida, Anna
    Pagan, Barbara
    del Valle Morales, Maria
    Salgado, Estuardo
    Maria Surinach, Jose
    Tolosa, Carles
    Monreal, Manuel
    MEDICINE, 2015, 94 (47) : e1944
  • [34] Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
    Fauchier, Laurent
    Blin, Patrick
    Sacher, Frederic
    Dureau-Pournin, Caroline
    Bernard, Marie-Agnes
    Lassalle, Regis
    Droz-Perroteau, Cecile
    Dallongeville, Jean
    Moore, Nicholas
    EUROPACE, 2020, 22 (02): : 205 - 215
  • [35] Risk of Bleeding and Venous Thromboembolism after Colorectal Cancer Surgery in Patients with and without Type 2 Diabetes: A Danish Cohort Study
    Kristensen, Frederik Pagh Bredahl
    Horvath-Puho, Erzsebet
    Szepliget, Szimonetta Komjathine
    Troelsen, Frederikke Schoenfeldt
    Sorensen, Henrik Toft
    TH OPEN, 2024, 08 (01) : e146 - e154
  • [36] Effectiveness and Safety of Rivaroxaban 15 mg Compared With Vitamin K Antagonists in Very Elderly Patients With Atrial Fibrillation, a Matched Cohort Study in the French Nationwide Claims Database SNIIRAM
    Fauchier, Laurent
    Blin, Patrick
    Sacher, Frederic
    Dureau-Pournin, Caroline
    Bernard, Marie-Agnes
    Lassalle, Regis
    Droz-Perroteau, Cecile
    Dallongeville, Jean
    Moore, Nicholas
    CIRCULATION, 2017, 136
  • [37] The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
    Yang, Kuang-Tsu
    Sun, Wei-Chih
    Tsai, Tzung-Jiun
    Tsay, Feng-Woei
    Chen, Wen-Chi
    Cheng, Jin-Shiung
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (01) : 1 - 16
  • [38] JAAD Game Changers*: Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study
    Lake, Eden
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (05) : 1274 - 1274
  • [39] JAAD Game Changers: Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study
    Lake, Eden
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (06) : 1815 - 1815
  • [40] Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM)
    Fauchier, Laurent
    Blin, Patrick
    Sacher, Frederic
    Dureau-Pournin, Caroline
    Bernard, Marie-Agnes
    Lassalle, Regis
    Droz-Perroteau, Cecile
    Dallongeville, Jean
    Moore, Nicholas
    BLOOD, 2017, 130
12345